Profit with us in the 2009 bear market
Research Report
Hotstocked.com has a complete research report available for JAV stock. Download JAV report.
Research Report
Get the full report for FREE
Date:Aug 13, 2009
Price:Free
Pages:4
Document Type:Adobe Acrobat Reader
 Download JAV report
  
Example preview: Research report for Javelin Pharmaceuticals, Inc (JAV) Research report for Javelin Pharmaceuticals, Inc (JAV) Research report for Javelin Pharmaceuticals, Inc (JAV) Research report for Javelin Pharmaceuticals, Inc (JAV)
   

News for Javelin Pharmaceuticals, Inc (JAV)

Markets Quote Depth/LII Options Charts News Company Financials Insiders Filings Analyst Earnings Historical
News ·  Blogs ·  Filings
Symbol:  | Recent Quotes powered by
  quotemedia.com
News for Javelin Pharmaceuticals Inc  (JAV) 
|
$ 1.47   0.07 (+5.00%) Volume: 319.22 k 4:00 PM EST Nov 20, 2009
After Hours:  $ 1.59   0.12 (+8.16%) Volume: 4.0 k 4:22 PM EST Nov 20, 2009
Tue, Nov 10, 2009
7:00 AM Javelin Pharmaceuticals, Inc. Reports Third Quarter 2009 Results - Business Wire
Wed, Nov 04, 2009
9:15 AM Javelin Pharmaceuticals to Announce Third Quarter 2009 Financial Results - Business Wire
Fri, Oct 30, 2009
9:25 AM Javelin Pharmaceuticals, Inc. Tops Up Balance Sheet Through Registered Direct Offering - Business Wire
Thu, Dec 04, 2008
9:33 AM NASDAQ OMX and Leerink Swann to Co-Host HealthCare Industry Forum - GlobeNewswire
Mon, Jan 22, 2007
9:00 AM American Stock Exchange to Host First Annual Healthcare Conference in Boston on February 8, 2007 - PR Newswire
Wed, Oct 25, 2006
7:45 AM Frost & Sullivan Names Javelin Pharmaceuticals Entrepreneurial Company of the Year for Intranasal Therapeutics - PR Newswire
Thu, Jul 20, 2006
9:57 AM American Stock Exchange Lists Common Stock of Javelin Pharmaceuticals, Inc. - PR Newswire
Thu, Jul 13, 2006
8:01 AM Javelin Pharmaceuticals, Inc. Receives Approval for Listing on the American Stock Exchange - PR Newswire
Fri, Jul 07, 2006
8:05 AM Javelin Pharmaceuticals Wins Phase II SBIR Grant - PR Newswire
Thu, Jul 06, 2006
11:26 AM Javelin Pharmaceuticals CEO to Present at Leerink Swann's Emerging Technologies in Pain Medicine Roundtable and Conference - PR Newswire
Wed, Jun 21, 2006
8:05 AM Mark Matthews Joins Javelin Pharmaceuticals as VP of Commercial Affairs - PR Newswire
Thu, Jun 15, 2006
8:30 AM Javelin Elects Martin Driscoll and Neil Flanzraich to Board - PR Newswire
Wed, May 31, 2006
11:42 AM Javelin Enrolls First Patient In Pivotal Phase III Postop Pain Study of Dyloject(TM) - PR Newswire
Wed, May 24, 2006
8:05 AM Javelin Pharmaceuticals' CEO to Present at Friedman, Billings, Ramsey's 2006 Growth Investor Conference - PR Newswire
Tue, May 23, 2006
8:05 AM Javelin Enrolls First Patient in Pivotal Phase III Study of Rylomine(TM) - PR Newswire
Mon, May 22, 2006
8:30 AM Javelin Pharmaceuticals' VP to Give Plenary Lecture at 2nd Annual Specialty Pharma Global Summit - PR Newswire
5:37 AM LaVoie Strategic Communications Group, Inc. Adds Three New Life Science Clients to Growing Roster - PR Newswire
Mon, May 15, 2006
1:01 PM GE Introduces New Series of Laptop-Size Ultrasound Systems to Expand Ultrasound's Role in Healthcare - US Equity News
11:09 AM Javelin Pharmaceuticals Reports First Quarter 2006 Results - PR Newswire
Wed, May 10, 2006
6:01 AM Javelin CEO to Present at Rodman & Renshaw 3rd Annual Global Healthcare Conference - PR Newswire
Thu, May 04, 2006
8:05 AM Javelin's Positive Rylomine(TM) Phase II Clinical Trial Data Presented at The American Pain Society Annual Meeting - PR Newswire
Mon, May 01, 2006
4:53 PM Javelin Announces Initial Results of a Pilot Phase II Study Of Intranasal Ketamine In Postoperative Orthopedic Pain - PR Newswire
Mon, Apr 24, 2006
8:05 AM Stephen Tulipano Joins Javelin Pharmaceuticals as Chief Financial Officer - PR Newswire
Mon, Apr 17, 2006
7:30 AM Javelin Pharmaceuticals Files Form 10-K for 2005 - PR Newswire
Wed, Apr 12, 2006
7:30 AM Leading IP Attorney, David Bernstein, Joins Javelin Pharmaceuticals - PR Newswire
  Page 1 of 2   Next Page

Copyright © QuoteMedia.   Data delayed 15 minutes unless otherwise indicated (View delay times for all exchanges).   RT   Realtime,  DL+   Realtime BATS,  EOD   End Of Day,  PD   Previous Day.   Market Data powered by QuoteMediaTerms of Use. 
   
 
Home > Companies > Javelin Pharmaceuticals, Inc